Meteora Capital’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Meteora Capital’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-235,256	Closed	-$2.55M	–	416
2023 Q3	$2.55M	Buy	235,256 +33	+0%	+$354	0.43%	63
2023 Q2	$2.51M	Sell	235,223 -674,248	-74%	-$7.09M	0.46%	71
2023 Q1	$9.49M	Buy	+909,471	New	+$9.42M	1.12%	16

Meteora Capital's BIOS Position: Q4 2023 in Review

Meteora Capital sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 235,256 shares — an estimated $2.55M sold.

Meteora Capital first reported a position in BIOS in Q1 2023 and held it in 3 quarters. The position peaked at $9.49M in Q1 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Meteora Capital reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Meteora Capital sold 235,256 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $2.55M.
Meteora Capital first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2023 and held it in 3 quarters.
Meteora Capital's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $9.49M in Q1 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Meteora Capital's 13F filing for Q4 2023, filed 14 Feb 2024.